Produktion von rekombinantem humanem Insulin

Biotechnologie trifft pharmazeutische Fertigung

Pharmaceutical & Drug Manufacturing Global Industrial Scale $35 billion

Übersicht

Recombinant human insulin is produced using genetically engineered Escherichia coli or Saccharomyces cerevisiae that express the human insulin gene. This biotechnological process replaced the previous method of extracting insulin from pig and cow pancreases, providing unlimited supply with reduced immunogenicity. The process involves fermentation, cell lysis, inclusion body solubilization, refolding, enzymatic modification, and multi-step chromatographic purification to produce pharmaceutical-grade insulin.

Chemischer Prozess

E. coli expressing proinsulin genes are fermented in large bioreactors. Inclusion bodies containing proinsulin are isolated, solubilized in urea, and the protein is refolded by controlled oxidation. Trypsin and carboxypeptidase B cleave the C-peptide to yield mature insulin, which is purified by reversed-phase and ion-exchange chromatography.

Proinsulin →[Trypsin + Carboxypeptidase B] Insulin (A-chain + B-chain linked by disulfide bonds) + C-peptide

Rohstoffe

  • Glucose (C₆H₁₂O₆) — Corn processing (Carbon source for fermentation)
  • Ammonium sulfate ((NH₄)₂SO₄) — Chemical synthesis (Nitrogen source)
  • Trypsin (enzyme) — Recombinant production (C-peptide cleavage)

Endprodukte

  • Recombinant human insulin — Diabetes treatment (>98% purity, multiple analog forms)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Fermentation-based production generates biological waste requiring sterilization before disposal. Chromatographic purification consumes significant water and buffer solutions. However, the environmental impact is far less than animal-sourced insulin which required millions of animal pancreases annually.

Sicherheitshinweise

Neuere Innovationen

Insulin analogs (lispro, glargine, aspart) with modified amino acid sequences provide faster or longer-acting profiles.
Cell-free protein synthesis and oral insulin delivery systems are in advanced development stages.

Mehr in Pharmaceutical & Drug Manufacturing

Aspirinsynthese durch Acetylierung von Salicylsäure

Global Industrial Scale

Halbsynthetische Produktion von Amoxicillin

Global Industrial Scale

Ibuprofensynthese – BHC-Grünprozess

Global Industrial Scale

Omeprazolsynthese für Protonenpumpenhemmer

Global Industrial Scale

Paracetamol-Synthese

Global Industrial Scale

Penicillin-G-Herstellung durch Fermentation

Global Industrial Scale

Synthese von Metforminhydrochlorid

Global Industrial Scale

Frequently Asked Questions

What industry uses Produktion von rekombinantem humanem Insulin?
Produktion von rekombinantem humanem Insulin is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Produktion von rekombinantem humanem Insulin?
E. coli expressing proinsulin genes are fermented in large bioreactors. Inclusion bodies containing proinsulin are isolated, solubilized in urea, and the protein is refolded by controlled oxidation. Trypsin and carboxypeptidase B cleave the C-peptide to yield mature insulin, which is purified by rev
What is the economic significance of Produktion von rekombinantem humanem Insulin?
Produktion von rekombinantem humanem Insulin has a market value of $35 billion.
What is the environmental impact of Produktion von rekombinantem humanem Insulin?
Fermentation-based production generates biological waste requiring sterilization before disposal. Chromatographic purification consumes significant water and buffer solutions. However, the environmental impact is far less than animal-sourced insulin which required millions of animal pancreases annua
What raw materials are used in Produktion von rekombinantem humanem Insulin?
The main raw materials include: Glucose (C₆H₁₂O₆), Ammonium sulfate ((NH₄)₂SO₄), Trypsin (enzyme).